Study identifies new metabolic target in quest to control immune response

September 5, 2017, University of Vermont
The discovery by Ayel Amiel, assistant professor at the University of Vermont in the Department of Medical Laboratory and Radiation Science, that dendritic cells have an internal source of glycogen is novel in that most research has focused on externally located glycogen stores. Credit: Sally McCay

A surprising discovery that immune cells possess an internal warehouse of glycogen used to activate immune responses could help to increase immune activity in vaccines or suppress immune reactions in autoimmune disease or hyper-inflammatory conditions.

Results of the new study in the journal Cell Metabolism show that the immune responses of are fueled by an intracellular storage of sugar as opposed to external sugar, where prior research has focused.

The novel finding adds an important missing piece to the puzzle of how early immune responses are powered from a metabolic standpoint, and provides immunologists with a new area of focus in their ongoing effort to regulate immune activity.

"By either enhancing or depleting this sugar warehouse within the cell, the hope would be that we could either influence or dampen immune reactions," says study author Eyal Amiel, assistant professor at the University of Vermont in the Department of Medical Laboratory and Radiation Science in the College of Nursing and Health Sciences. "What we're really in the business of is finding new switches to toggle to that effect and this finding provides us with a new regulatory target that regulates ."

The finding gives immunologists a key piece of new information to better understand how the early part of the bioenergetics of a dendritic cell immune response is generated. This is especially significant given the importance of timing when it comes to immune response and the speed at which the switch of inflammation can be either increased or suppressed.

"What's surprising is that the intracellular sugar pool is the more important one early on," says Amiel, who co-authored the paper with Phyu Thwe, a Ph.D. student in Amiel's lab, and three external researchers. "The reason that is so important is because in any kind of immune protection scenario it is absolutely a race against time between the microbe and mammalian immune response."

When Amiel and his colleagues impaired the ability of dendritic to access the internal warehouse of sugar, the cells were less effective at stimulating an in a number of measurable ways. "The really exciting thing is we believe our findings likely extend to other cells of the immune system and are not dendritic cell-specific" says Amiel.

In a previous paper in Nature Immunology, Amiel and lead author Bart Everts, assistant professor at the Leiden University Medical center in the Netherlands, found that the early consumption of glucose is vital to the activation of cells, in terms of the production and secretion of proteins that are essential to the cells' .

Amiel has started conducting new research on mice only with deficiencies in glycogen synthesis only in dendritic cells to measure the impact of blocking the creation of the intracellular glycogen supply on the longer-term immunological capacity of those cells.

"We know that if we prevent their ability to use glycogen during that early window there are long-term consequences for the abilities of those dendritic cells to stimulate T-Cells, even hours and days after the fact."

Explore further: Not such a 'simple' sugar—glucose may help fight cancer and inflammatory disease

Related Stories

Not such a 'simple' sugar—glucose may help fight cancer and inflammatory disease

May 30, 2017
Glucose - commonly referred to as a 'simple' sugar - may actually be crucial in the fight against cancer and inflammatory disease as scientists have just discovered a new role in which it stimulates cells that work on the ...

Allergies? Exhausted regulatory T cells may play a role

August 24, 2017
Researchers have evidence that the specialized T cells responsible for maintaining a balanced immune response are vulnerable to exhaustion that disrupts normal functioning and may even contribute to allergic reactions. St. ...

Dendritic cell research a step toward improved vaccines, immune health

March 19, 2014
(Medical Xpress)—Eyal Amiel didn't think he wanted to study immunology, let alone make a career of it. But as co-author of a paper recently published in the journal Nature Immunology, Amiel, assistant professor in the Department ...

Partnering cells turn off immune attack on pancreatic tumors

July 18, 2017
Two cell types work together to protect pancreatic tumors from destruction by the immune system. But, blocking this partnership may restore the system's ability to attack these same tumor cells.

How genetically engineered viruses develop into effective vaccines

July 26, 2017
Lentiviral vectors are virus particles that can be used as a vaccine to stimulate the immune system to fight against specific pathogens. The vectors are derived from HIV, rendered non-pathogenic, and then engineered to carry ...

Battle hymns and lullabies: Scientist sheds light on the T cell orchestra

October 27, 2016
In research published in the prestigious journal Immunity, a Saint Louis University researcher reports new findings that help understand how the immune system's dendritic cells direct other immune cells called T lymphocytes ...

Recommended for you

Genomics reveals key macrophages' involvement in systemic sclerosis

January 18, 2018
A new international study has made an important discovery about the key role of macrophages, a type of immune cell, in systemic sclerosis (SSc), a chronic autoimmune disease which currently has no cure.

First vaccine developed against grass pollen allergy

January 18, 2018
Around 400 million people worldwide suffer in some form or other from a grass pollen allergy (rhinitis), with the usual symptoms of runny nose, cough and severe breathing problems. In collaboration with the Viennese firm ...

Researchers discover key driver of atopic dermatitis

January 17, 2018
Severe eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that is driven by an allergic reaction. In their latest study, researchers at La Jolla Institute reveal an important player that promotes ...

Who might benefit from immunotherapy? New study suggests possible marker

January 16, 2018
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments.

Researchers identify new way to unmask melanoma cells to the immune system

January 16, 2018
system, which enables these deadly skin cancers to grow and spread.

How the immune system's key organ regenerates itself

January 15, 2018
With advances in cancer immunotherapy splashing across headlines, the immune system's powerful cancer assassins—T cells—have become dinner-table conversation. But hiding in plain sight behind that "T" is the organ from ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.